Walking Sensation Study
NCT: NCT06975423 · RECRUITING
Brief Summary
The primary objective of this new line of research is to test whether augmenting sensory information from the legs, using Walkasins sensory neuroprosthesis, can enhance performance of a complex walking task in older adults with foot sensory impairment. The overarching hypothesis is that Walkasins will enhance the automaticity and reduce cognitive demand of walking in older adults with foot sensory impairments, as measured by reduced prefrontal activity, decreased dual-task costs, and lower gait variability.
Frequently Asked Questions
What is Walking Sensation Study?
Walking Sensation Study is a clinical trial registered under NCT06975423. Current status: RECRUITING.
What is the status of NCT06975423?
The current status of NCT06975423 (Walking Sensation Study) is: RECRUITING.
When did Walking Sensation Study start?
Walking Sensation Study started on 2025-09-08.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.